Roles of coagulation pathway and factor Xa in rat mesangioproliferative glomerulonephritis

被引:22
作者
Nomura, Keiko
Liu, Ning
Nagai, Kojiro
Hasegawa, Takamichi
Kobayashi, Ikei
Nogaki, Fumiaki
Tanaka, Misa
Arai, Hidenori
Fukatsu, Atsushi
Kita, Toru
Ono, Takahiko
机构
[1] Univ Shizuoka, Sch Pharmaceut Sci, Div Mol Med, Shizuoka 4228526, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Geriatr Med, Kyoto, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan
关键词
factor X; factor V; PAR2; DX-9065a; inflammation;
D O I
10.1038/labinvest.3700502
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tissue factor initiates the extrinsic coagulation pathway by activating coagulation factor X to factor Xa, and factor V is a cofactor for the prothrombin activation by factor Xa. As factor Xa is known to promote the proliferation of mesangial cells in culture, the roles of the coagulation pathway and factor Xa were studied in an animal model of mesangioproliferative glomerulonephritis (MsPGN). MsPGN was induced in Wistar rats by an intravenous injection of anti-Thy 1.1 monoclonal antibody, OX-7. To clarify the role of factor Xa in MsPGN, a specific factor Xa inhibitor, DX-9065a, was injected intravenously at 2.5 or 10 mg/kg at the same time as OX-7, and kidney involvement was assessed by immunohistological analyses. We also examined p44/42 mitogen-activated protein (MAP) kinase activation. Time-course study revealed that expressions of tissue factor, factor V, and protease-activated receptor 2 (PAR2) were peaked on day 3, followed by factor X accumulation and mesangial proliferation. DX-9065a treatment significantly ameliorated proteinuria in a dose-dependent manner on day 8. Histological analyses showed a significant reduction in the size of glomeruli, the total number of glomerular cells, and crescent formation by DX-9065a treatment. Macrophage infiltration, which was rapidly observed on day I in disease control rats was not inhibited on days 1-3 by DX-9065a treatment, however it was suppressed on days 5-8. The deposition of fibrin, the number of PCNA-positive cells, and phosphorylation of p44/42 MAP kinase were markedly increased in the disease control group, whereas they were significantly reduced in the treatment group. Tissue factor and factor V induction may accelerate MsPGN through the activation and accumulation of factor X via proinflammatory and procoagulant mechanisms, and the inhibition of factor Xa would be a promising method to regulate the disease process.
引用
收藏
页码:150 / 160
页数:11
相关论文
共 49 条
  • [1] Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI pilot
    Alexander, JH
    Dyke, CK
    Yang, H
    Becker, RC
    Hasselblad, V
    Zillman, LA
    Kleiman, NS
    Hochman, JS
    Berger, PB
    Cohen, EA
    Lincoff, AM
    Saint-Jacques, H
    Chetcuti, S
    Burton, JR
    Buergler, JM
    Spence, FP
    Shimoto, Y
    Robertson, TL
    Kunitada, S
    Bovill, EG
    Armstrong, PW
    Harrington, RA
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (02) : 234 - 241
  • [2] BAGCHUS WM, 1986, LAB INVEST, V55, P680
  • [3] In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis
    Bokemeyer, D
    Panek, D
    Kramer, HJ
    Lindemann, M
    Kitahara, M
    Boor, P
    Kerjaschki, D
    Trzaskos, JM
    Floege, J
    Ostendorf, T
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (06): : 1473 - 1480
  • [4] Bokemeyer D, 2000, J AM SOC NEPHROL, V11, P232, DOI 10.1681/ASN.V112232
  • [5] Multiple intracellular MAP kinase signaling cascades
    Bokemeyer, D
    Sorokin, A
    Dunn, MJ
    [J]. KIDNEY INTERNATIONAL, 1996, 49 (05) : 1187 - 1198
  • [6] Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells
    Camerer, E
    Kataoka, H
    Kahn, M
    Lease, K
    Coughlin, SR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (18) : 16081 - 16087
  • [7] Thrombin signalling and protease-activated receptors
    Coughlin, SR
    [J]. NATURE, 2000, 407 (6801) : 258 - 264
  • [8] Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis
    Cunningham, MA
    Ono, T
    Hewitson, TD
    Tipping, PG
    Becker, GJ
    Holdsworth, SR
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (04) : 1311 - 1318
  • [9] Receptors of the PAR-family as a link between blood coagulation and inflammation
    Dugina, TN
    Kiseleva, EV
    Chistov, IV
    Umarova, BA
    Strukova, SM
    [J]. BIOCHEMISTRY-MOSCOW, 2002, 67 (01) : 65 - 74
  • [10] Erlich JH, 1997, AM J PATHOL, V150, P873